Baidu
map

J Endod:新型高可塑性MTA材料的细胞毒性、生物相容性和生物矿化作用分析

2017-03-27 MedSci MedSci原创

MTA具有极好的生物特性,但其操作性较差,如:ProRoot MTA (Tulsa Dental Products, Tulsa, OK)和white MTA-Angelus (MTA-Ang; Angelus Indústria de Produtos Odontológicos S/A, Londrina, PR, Brazil)。近来,高可塑性MTA-Angelus(MTA-Angelus

MTA具有极好的生物特性,但其操作性较差,如:ProRoot MTA (Tulsa Dental Products, Tulsa, OK)和white MTA-Angelus (MTA-Ang; Angelus Indústria de Produtos Odontológicos S/A, Londrina, PR, Brazil)。近来,高可塑性MTA-Angelus(MTA-Angelus HP)面世,有望解决MTA操作性差的问题。然而,考虑到材料在使用过程中与组织直接接触,需要评估MTA-Angelus HP的细胞毒性、生物相容性和生物矿化能力,观察其与常规white MTA-Ang的生物性能差异。

方法:L929成纤维细胞系常规培养。分别在6、24、48和72 h,阿拉玛蓝(Thermo Fisher Scientific, Waltham, MA)测定细胞活性。20只Wistar大鼠皮下分别埋植装有1种MTA材料的聚乙烯管或空管(对照)。在植入后的7天和30天,管及其周围组织常规取材,通过HE染色、或von Kossa染色、又或偏振光观察检测材料的生物相容性。结果进行统计学分析(P<0.05)。

结果显示,与对照组相比,MTA HP在24、48和72 h时细胞活性显着提高(P<0.05)。72 h时,MTA HP组的细胞活性明显高于white MTA-Ang(P<0.05)。植入后7天,组织学结果显示,所有组均表现出中等程度炎症反应和一层较厚的纤维囊(P>0.05)。植入后30天,所有组均表现出较弱的炎症反应和一层较薄的纤维囊(P>0.05)。所有材料周围的组织结构von Kossa染色均呈阳性,并且偏振光显示双折射。

结论:MTA HP表现出与white MTA-Ang相似的生物相容性和生物矿化能力。除此之外,与white MTA-Ang相比,MTA HP可以在较长时间内增加成纤维细胞的活力。

原始出处:

Cintra LT, Benetti F, et al. Cytotoxicity, Biocompatibility, and Biomineralization of the New High-plasticity MTA Material. J Endod. 2017 Mar 17. pii: S0099-2399(16)31064-0. doi: 10.1016/j.joen.2016.12.018.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=185359, encodeId=d82a18535910, content=期待M丅A一HP应用中国临床!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzbCrNlTIlTfsCoY1L9dvM1PibZhOWaeleTdib3jyTEEIppUnGkyuurLZ9ZCYNydgVQbNPicgTGASbJe/0, createdBy=cbaa2004663, createdName=山丫, createdTime=Wed Apr 05 17:51:01 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1721302, encodeId=37651e2130227, content=<a href='/topic/show?id=0143e3298c3' target=_blank style='color:#2F92EE;'>#矿化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73298, encryptionId=0143e3298c3, topicName=矿化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a5532986439, createdName=yahu, createdTime=Sun Feb 25 08:00:00 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368020, encodeId=9ac81368020fa, content=<a href='/topic/show?id=de4912308e7' target=_blank style='color:#2F92EE;'>#MTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12308, encryptionId=de4912308e7, topicName=MTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Tue Mar 28 15:00:00 CST 2017, time=2017-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529507, encodeId=4f23152950eae, content=<a href='/topic/show?id=a02ce793707' target=_blank style='color:#2F92EE;'>#细胞毒性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77937, encryptionId=a02ce793707, topicName=细胞毒性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10b211951227, createdName=appleandpeer, createdTime=Tue Mar 28 15:00:00 CST 2017, time=2017-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586628, encodeId=2c1715866282f, content=<a href='/topic/show?id=155269406ec' target=_blank style='color:#2F92EE;'>#生物相容性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69406, encryptionId=155269406ec, topicName=生物相容性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6cb17357412, createdName=bnurmamat, createdTime=Tue Mar 28 15:00:00 CST 2017, time=2017-03-28, status=1, ipAttribution=)]
    2017-04-05 山丫

    期待M丅A一HP应用中国临床!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=185359, encodeId=d82a18535910, content=期待M丅A一HP应用中国临床!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzbCrNlTIlTfsCoY1L9dvM1PibZhOWaeleTdib3jyTEEIppUnGkyuurLZ9ZCYNydgVQbNPicgTGASbJe/0, createdBy=cbaa2004663, createdName=山丫, createdTime=Wed Apr 05 17:51:01 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1721302, encodeId=37651e2130227, content=<a href='/topic/show?id=0143e3298c3' target=_blank style='color:#2F92EE;'>#矿化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73298, encryptionId=0143e3298c3, topicName=矿化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a5532986439, createdName=yahu, createdTime=Sun Feb 25 08:00:00 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368020, encodeId=9ac81368020fa, content=<a href='/topic/show?id=de4912308e7' target=_blank style='color:#2F92EE;'>#MTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12308, encryptionId=de4912308e7, topicName=MTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Tue Mar 28 15:00:00 CST 2017, time=2017-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529507, encodeId=4f23152950eae, content=<a href='/topic/show?id=a02ce793707' target=_blank style='color:#2F92EE;'>#细胞毒性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77937, encryptionId=a02ce793707, topicName=细胞毒性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10b211951227, createdName=appleandpeer, createdTime=Tue Mar 28 15:00:00 CST 2017, time=2017-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586628, encodeId=2c1715866282f, content=<a href='/topic/show?id=155269406ec' target=_blank style='color:#2F92EE;'>#生物相容性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69406, encryptionId=155269406ec, topicName=生物相容性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6cb17357412, createdName=bnurmamat, createdTime=Tue Mar 28 15:00:00 CST 2017, time=2017-03-28, status=1, ipAttribution=)]
    2018-02-25 yahu
  3. [GetPortalCommentsPageByObjectIdResponse(id=185359, encodeId=d82a18535910, content=期待M丅A一HP应用中国临床!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzbCrNlTIlTfsCoY1L9dvM1PibZhOWaeleTdib3jyTEEIppUnGkyuurLZ9ZCYNydgVQbNPicgTGASbJe/0, createdBy=cbaa2004663, createdName=山丫, createdTime=Wed Apr 05 17:51:01 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1721302, encodeId=37651e2130227, content=<a href='/topic/show?id=0143e3298c3' target=_blank style='color:#2F92EE;'>#矿化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73298, encryptionId=0143e3298c3, topicName=矿化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a5532986439, createdName=yahu, createdTime=Sun Feb 25 08:00:00 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368020, encodeId=9ac81368020fa, content=<a href='/topic/show?id=de4912308e7' target=_blank style='color:#2F92EE;'>#MTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12308, encryptionId=de4912308e7, topicName=MTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Tue Mar 28 15:00:00 CST 2017, time=2017-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529507, encodeId=4f23152950eae, content=<a href='/topic/show?id=a02ce793707' target=_blank style='color:#2F92EE;'>#细胞毒性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77937, encryptionId=a02ce793707, topicName=细胞毒性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10b211951227, createdName=appleandpeer, createdTime=Tue Mar 28 15:00:00 CST 2017, time=2017-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586628, encodeId=2c1715866282f, content=<a href='/topic/show?id=155269406ec' target=_blank style='color:#2F92EE;'>#生物相容性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69406, encryptionId=155269406ec, topicName=生物相容性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6cb17357412, createdName=bnurmamat, createdTime=Tue Mar 28 15:00:00 CST 2017, time=2017-03-28, status=1, ipAttribution=)]
    2017-03-28 liuxiaona
  4. [GetPortalCommentsPageByObjectIdResponse(id=185359, encodeId=d82a18535910, content=期待M丅A一HP应用中国临床!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzbCrNlTIlTfsCoY1L9dvM1PibZhOWaeleTdib3jyTEEIppUnGkyuurLZ9ZCYNydgVQbNPicgTGASbJe/0, createdBy=cbaa2004663, createdName=山丫, createdTime=Wed Apr 05 17:51:01 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1721302, encodeId=37651e2130227, content=<a href='/topic/show?id=0143e3298c3' target=_blank style='color:#2F92EE;'>#矿化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73298, encryptionId=0143e3298c3, topicName=矿化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a5532986439, createdName=yahu, createdTime=Sun Feb 25 08:00:00 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368020, encodeId=9ac81368020fa, content=<a href='/topic/show?id=de4912308e7' target=_blank style='color:#2F92EE;'>#MTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12308, encryptionId=de4912308e7, topicName=MTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Tue Mar 28 15:00:00 CST 2017, time=2017-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529507, encodeId=4f23152950eae, content=<a href='/topic/show?id=a02ce793707' target=_blank style='color:#2F92EE;'>#细胞毒性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77937, encryptionId=a02ce793707, topicName=细胞毒性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10b211951227, createdName=appleandpeer, createdTime=Tue Mar 28 15:00:00 CST 2017, time=2017-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586628, encodeId=2c1715866282f, content=<a href='/topic/show?id=155269406ec' target=_blank style='color:#2F92EE;'>#生物相容性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69406, encryptionId=155269406ec, topicName=生物相容性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6cb17357412, createdName=bnurmamat, createdTime=Tue Mar 28 15:00:00 CST 2017, time=2017-03-28, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=185359, encodeId=d82a18535910, content=期待M丅A一HP应用中国临床!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzbCrNlTIlTfsCoY1L9dvM1PibZhOWaeleTdib3jyTEEIppUnGkyuurLZ9ZCYNydgVQbNPicgTGASbJe/0, createdBy=cbaa2004663, createdName=山丫, createdTime=Wed Apr 05 17:51:01 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1721302, encodeId=37651e2130227, content=<a href='/topic/show?id=0143e3298c3' target=_blank style='color:#2F92EE;'>#矿化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73298, encryptionId=0143e3298c3, topicName=矿化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a5532986439, createdName=yahu, createdTime=Sun Feb 25 08:00:00 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368020, encodeId=9ac81368020fa, content=<a href='/topic/show?id=de4912308e7' target=_blank style='color:#2F92EE;'>#MTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12308, encryptionId=de4912308e7, topicName=MTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Tue Mar 28 15:00:00 CST 2017, time=2017-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529507, encodeId=4f23152950eae, content=<a href='/topic/show?id=a02ce793707' target=_blank style='color:#2F92EE;'>#细胞毒性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77937, encryptionId=a02ce793707, topicName=细胞毒性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10b211951227, createdName=appleandpeer, createdTime=Tue Mar 28 15:00:00 CST 2017, time=2017-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586628, encodeId=2c1715866282f, content=<a href='/topic/show?id=155269406ec' target=_blank style='color:#2F92EE;'>#生物相容性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69406, encryptionId=155269406ec, topicName=生物相容性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6cb17357412, createdName=bnurmamat, createdTime=Tue Mar 28 15:00:00 CST 2017, time=2017-03-28, status=1, ipAttribution=)]

相关资讯

J Endod:MTA通过抑制自体吞噬通路抗破骨发生

MTA可以调控骨重建,特别是破骨细胞的分化。然而,MTA抗破骨发生的潜在分子机制还未可知。这篇报道的目的是在体外研究MTA抗破骨发生过程中,自噬通路可能发生的改变以及潜在的机制。

J Endod:MTA促进人牙周膜再生成功的首例临床证据

这篇报道是为了验证MTA在应用于人牙髓治疗过程中,是否能像在动物模型中一样,可以促进根尖周组织的再生。

Baidu
map
Baidu
map
Baidu
map